PMID- 21049972 OWN - NLM STAT- MEDLINE DCOM- 20121127 LR - 20230106 IS - 1520-4995 (Electronic) IS - 0006-2960 (Print) IS - 0006-2960 (Linking) VI - 50 IP - 1 DP - 2011 Jan 11 TI - Structure, energetics, and dynamics of binding coactivator peptide to the human retinoid X receptor alpha ligand binding domain complex with 9-cis-retinoic acid. PG - 93-105 AB - Retinoid X receptors (RXRs) are ligand-dependent nuclear receptors, which are activated by the potent agonist 9-cis-retinoic acid (9cRA). 9cRA binds to the ligand binding domain (LBD) of RXRs and recruits coactivator proteins for gene transcription. Using isothermal titration calorimetry, the binding of a 13-mer coactivator peptide, GRIP-1, to the hRXRalpha-LBD homodimer complex containing 9cRA (hRXRalpha-LBD:9cRA:GRIP-1) is reported between 20 and 37 degrees C. DeltaG is temperature independent (-8.5 kcal/mol), and GRIP-1 binding is driven by DeltaH (-9.2 kcal/mol) at 25 degrees C. DeltaC(p) is large and negative (-401 cal mol(-1) K(-1)). The crystal structure of hRXRalpha-LBD:9cRA:GRIP-1 is reported at 2.05 A. When the structures of hRXRalpha-LBD:9cRA:GRIP-1 and hRXRalpha-LBD:9cRA ( 1FBY ) homodimers are compared, E453 and E456 on helix 12 bury and form ionic interactions with GRIP-1. R302 on helix 4 realigns to form new salt bridges to both E453 and E456. F277 (helix 3), F437 (helix 11), and F450 (helix 12) move toward the hydrophobic interior. The changes in the near-UV spectrum at 260 nm of the hRXRalpha-LBD:9cRA:GRIP-1 support this structural change. Helix 11 tilts toward helix 12 by approximately 1 A, modifying the ring conformation of 9cRA. Hydrogen-deuterium exchange mass spectroscopy indicates GRIP-1 binding to hRXRalpha-LBD:9cRA significantly decreases the exchange rates for peptides containing helices 3 (F277), 4 (R302), 11 (F437), and 12 (E453, E456). The structural changes and loss of dynamics of the GRIP-1-bound structure are used to interpret the energetics of coactivator peptide binding to the agonist-bound hRXRalpha-LBD. FAU - Xia, Gang AU - Xia G AD - Department of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States. FAU - Boerma, LeeAnn J AU - Boerma LJ FAU - Cox, Bryan D AU - Cox BD FAU - Qiu, Cheng AU - Qiu C FAU - Kang, Sebyung AU - Kang S FAU - Smith, Craig D AU - Smith CD FAU - Renfrow, Matthew B AU - Renfrow MB FAU - Muccio, Donald D AU - Muccio DD LA - eng SI - PDB/3OAP GR - RR17261/RR/NCRR NIH HHS/United States GR - P50 CA089019/CA/NCI NIH HHS/United States GR - 2 P50 CA089019/CA/NCI NIH HHS/United States GR - S10 RR017261/RR/NCRR NIH HHS/United States GR - 5 P50CA089019/CA/NCI NIH HHS/United States GR - P50 CA089019-09/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20101208 PL - United States TA - Biochemistry JT - Biochemistry JID - 0370623 RN - 0 (Ligands) RN - 0 (Nuclear Receptor Coactivator 2) RN - 0 (Retinoid X Receptor alpha) RN - 1UA8E65KDZ (Alitretinoin) RN - 5688UTC01R (Tretinoin) SB - IM MH - Alitretinoin MH - Amino Acid Sequence MH - Crystallography, X-Ray MH - Humans MH - Ligands MH - Models, Molecular MH - Molecular Sequence Data MH - Nuclear Receptor Coactivator 2/chemistry/*metabolism MH - Protein Binding MH - Protein Multimerization MH - Protein Structure, Tertiary MH - Retinoid X Receptor alpha/chemistry/*metabolism MH - Spectrophotometry, Ultraviolet MH - Thermodynamics MH - Tretinoin/chemistry/*metabolism PMC - PMC3081989 MID - NIHMS257563 EDAT- 2010/11/06 06:00 MHDA- 2012/12/10 06:00 PMCR- 2012/06/08 CRDT- 2010/11/06 06:00 PHST- 2010/11/06 06:00 [entrez] PHST- 2010/11/06 06:00 [pubmed] PHST- 2012/12/10 06:00 [medline] PHST- 2012/06/08 00:00 [pmc-release] AID - 10.1021/bi101288y [doi] PST - ppublish SO - Biochemistry. 2011 Jan 11;50(1):93-105. doi: 10.1021/bi101288y. Epub 2010 Dec 8.